Cite
HARVARD Citation
Trummer, A. et al. (2022). NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy. Lung cancer. pp. 141-145. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Trummer, A. et al. (2022). NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy. Lung cancer. pp. 141-145. [Online].